Literature DB >> 20369815

Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins.

André J van der Vlies1, Conlin P O'Neil, Urara Hasegawa, Nathan Hammond, Jeffrey A Hubbell.   

Abstract

Previously we reported emulsion polymerization of propylene sulfide with Pluronic F127 as an emulsifier, yielding nanoparticles (NPs) in the 25 nm size range. Immunologically functional NPs were prepared by adding an antigen-Pluronic conjugate to the polymerization mixture ( Reddy , S. T. , et al. ( 2007 ) Nat. Biotechnol. 25, 1159 ). We sought a more flexible scheme for conjugation of antigens and other biomolecules to the NP surfaces that would allow for milder reaction conditions than achievable during the polymerization step. Here, we present the synthesis of such functionalizable NPs in the form of NPs that carry thiol-reactive groups, to which thiol-containing antigens (peptide or protein) or other biomolecules can be conjugated under mild conditions to yield immunofunctional NPs. The Pluronic-stabilized poly(propylene sulfide) (PPS) NPs with thiol-reactive pyridyl disulfide groups are prepared in two steps by (1) emulsion polymerization of propylene sulfide in the presence of a carboxylate-Pluronic and (2) reaction of the carboxylic acid groups on the NP surface with cysteamine pyridyl disulfide and a water-soluble carbodiimide reagent. We choose pyridyl disulfide groups to have a reduction-sensitive disulfide bond linking the antigen to the NP surface, allowing efficient release of antigen inside the cell in response to the reductive conditions within the endosome. The functionalizable NPs are characterized by proton NMR, dynamic light scattering (DLS), UV/vis spectroscopy, and transmission electron microscopy (TEM). Conjugation of small molecules and protein to the NP surface is presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20369815     DOI: 10.1021/bc9004443

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  26 in total

1.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.

Authors:  Chiara Nembrini; Armando Stano; Karen Y Dane; Marie Ballester; André J van der Vlies; Benjamin J Marsland; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  S-Nitrosated Polypropylene Sulfide Nanoparticles for Thiol-Dependent Transnitrosation and Toxicity Against Adult Female Filarial Worms.

Authors:  Alex Schudel; Timothy Kassis; J Brandon Dixon; Susan N Thomas
Journal:  Adv Healthc Mater       Date:  2015-05-04       Impact factor: 9.933

Review 4.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

Review 5.  Chemoenzymatic method for glycomics: Isolation, identification, and quantitation.

Authors:  Shuang Yang; Abigail Rubin; Shadi Toghi Eshghi; Hui Zhang
Journal:  Proteomics       Date:  2015-11-06       Impact factor: 3.984

6.  Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation.

Authors:  Joshua D Thomas; Terrence R Burke
Journal:  Tetrahedron Lett       Date:  2011-08-17       Impact factor: 2.415

Review 7.  Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.

Authors:  Brittany E Givens; Sean M Geary; Aliasger K Salem
Journal:  Immunotherapy       Date:  2018-03-23       Impact factor: 4.196

8.  Intracellular Cleavable CpG Oligodeoxynucleotide-Antigen Conjugate Enhances Anti-tumor Immunity.

Authors:  Katrin Kramer; Nicholas J Shields; Viola Poppe; Sarah L Young; Greg F Walker
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 9.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

10.  Lymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes.

Authors:  Lauren F Sestito; Susan N Thomas
Journal:  Biomaterials       Date:  2020-09-18       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.